权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Semi-supervised Approaches to Denoising Electronic Health Records Data for Risk Prediction

用于风险预测的电子健康记录数据去噪半监督方法

基本信息

批准号：
10453558
负责人：
TIANXI CAI
金额：
$ 33.74万
依托单位：
HARVARD SCHOOL OF PUBLIC HEALTH
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-08-01 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10453558
关键词：
Address Adoption Aftercare Algorithms Biological Clinical Clinical Data Clinical Investigator Clinical Trials Code Cohort Studies Colon Carcinoma Colorectal Cancer Complex Computer software Computerized Medical Record Data Data Set Development Dimensions Disease Disease Outcome Disease Progression Electronic Health Record Face Factor X Genes Goals Gold Healthcare Healthcare Systems Heterogeneity Human Inflammatory Inflammatory Bowel Diseases Label Learning Malignant Neoplasms Massachusetts Measurement Medical Genetics Medical Records Meta-Analysis Methodology Methods Modeling Oncology Outcome Patients Population Procedures Registries Research Research Activity Research Proposals Risk Risk Estimate Risk Factors Site Source Specimen Statistical Algorithm Statistical Methods Supervision System TNF gene Target Populations Testing Training Translational Research Validation adalimumab antagonist base biobank burden of illness clinical application clinical practice cohort colon cancer risk cost cost effective deep learning denoising disorder risk electronic data genomic data high dimensionality improved individualized medicine infliximab large datasets learning strategy machine learning method machine learning model multiple data sources novel outcome prediction patient population patient privacy personalized management personalized predictions personalized risk prediction precision medicine predictive modeling programs repository risk prediction risk prediction model study population supervised learning tool transfer learning treatment response user-friendly

项目摘要

Project Summary While clinical trials remain a critical source for oncology research, their study findings may not be gener- alizable to the real world due to the restricted patient population. In recent years, due to the increasing adoption of electronic health records (EHR) and the linkage of EHR with specimen bio-repositories and other research registries, integrated large datasets now exist as a new source for translational research. These integrated datasets open opportunities for developing accurate EHR-based prediction models for disease progression and treatment response, which can be easily incorporated into clinical practice. These models can also be contrasted with models derived from clinical trials, bridging the gap between clinical trials and the real world. However, efficiently deriving and evaluating personalized prediction models using such real world data (RWD) remains challenging due to practical and methodological obstacles. For example, validated outcome information from EHR, such as development of colon cancer and 1-year treatment response, requires laborious medical record review and hence is often not readily available for research. Naive use of error prone surrogates of the outcome, such as billing codes or procedure codes, as the true outcome may greatly hamper the power of EHR studies and produce biased results. Semi-supervised risk prediction methods, leveraging noisy surrogates and a small amount of human annotations on the outcome, may greatly improve the utility of EHR for precision medicine research. Deriving a precise estimate of the risk model becomes even more challenging when the number of candidate features is not small relative to the number of annotated outcomes. Another major challenge with EHR risk modeling lies in the transportability. Complex machine learning models trained in one EHR system often attain low accuracy in another EHR system, due to the heterogeneity in the patient population and healthcare system. Transfer learning methods that can automatically adjust model developed for one EHR cohort to better fit to another EHR cohort is of great value. Synthesizing information from multiple data sources can improve the quality of evidence. However, meta analyzing EHR from multiple EHR cohorts faces an additional challenge due to patient privacy. We address these challenges by developing semi-supervised risk prediction methods with high dimensional predictions in Aim 1; semi-supervised transfer learning methods to enable risk prediction modeling in target populations with no gold standard labels uted learin Aim 2; and distributed learning methods for high dimensional predictive modeling in Aim.

项目总结